Adjuvants are not active ingredients for the purposes of SPC protection
The Court of Justice of the European Union (CJEU) has released a ‘reasoned order’ in the GSK Biologicals SA case (C-210/13). The conclusion is that an adjuvant to a vaccine is not an active ingredient and so a vaccine/adjuvant combination is not a product capable of SPC protection…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
A ratchet is a structure whereby the eventual equity allocations between the shareholders depend on future performance of the company or the rate of return achieved by the venture capital firm.
The venture capital investors in an investment round normally require that certain actions cannot be taken without the consent of the holders of a majority of their class or series of shares.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town